‘Precision Medicine’ Gets R&D Funding Push In President’s Speech
This article was originally published in The Pink Sheet Daily
President Obama highlights potential for personalized medicine in his State of the Union address and will seek a “major increase” in research and development funding.
You may also be interested in...
Compared to House's 21st Century Cures package, Senate's Healthier Americans initiative is tiny, but if nothing else bills will lay important groundwork for user fee legislation.
CDER Director Woodcock says agency should write down its definition of a surrogate endpoint, but industry and academics will have to help with requirements for biomarker approval.
In an interview with “The Pink Sheet,” new deputy commissioner for medical products says FDA needs better ways of helping stakeholders, public understand agency thinking.